The Indian Council of Medical Research (ICMR) established an expert committee in 2023 for the Evaluation of Vector Control Products (EVCP) according to the ICMR Common Protocol for Uniform Evaluation of Public Health Pesticides (3 rd edition, 2023).
EVCP Terms of Reference:
1. To review applications received from original manufacturers of vector control products and determine eligibility of the submitted products for efficacy evaluation.
2. To determine the evaluation pathway or phases of evaluation according to the efficacy data requirements of the Central Insecticides Board & Registration Committee (CIB&RC) and the ICMR Common Protocol.
3. To allocate candidate products to eligible laboratories for laboratory and/or field evaluation of their insecticidal efficacy and other related parameters according to the Common Protocol.
4. To review suitability of the protocols of the laboratory studies and/or field trials.
5. To oversee progress of laboratory and field evaluations conducted by designated institutions, and review the outcomes of these studies.
6. To provide stewardship support to prospective manufacturers who intend to submit, or have submitted, their products in terms of technical eligibility, selection of vector species according to the product type or its mode of action, data requirements according to the Common Protocol, availability of institutions to conduct the evaluation and study timelines.
7. To advise, on demand, ICMR, CIBR&C, NCVBDC and NCDC on technical issues around product evaluation.
8. To coordinate review of the Common Protocol and facilitate its revision according to the contemporary requirements and latest WHO or national guidelines.
The EVCP ensures that vector control products meet established standards of efficacy, thereby generating reliable evidence to support regulatory approval and informed public health decision-making for control of vector-borne diseases such as malaria, dengue, chikungunya, filariasis, leishmaniasis.
EVCP Committee Members
1. Dr Rajpal S. Yadav, Former Head of WHO Pesticide Evaluation Scheme (WHOPES) & Chair of the WHO Joint Action Group on Global Vector Control Response, World Health Organization, Geneva, Switzerland (based in Gurugram, Haryana) – Chairperson
2. Dr K. Gunasekaran, Former Scientist-G, ICMR-VCRC, Puducherry – Member
3. Dr R.M. Bhatt, Former Scientist-F, ICMR-NIMR, Raipur (based in Ahmedabad)– Member
4. Dr Ashwani Kumar, Vice Chancellor, Saveetha Institute of Medical & Technical Sciences, Chennai; Former Director, ICMR-VCRC, Puducherry– Member
5. Dr Sumitra Arora, Principal Scientist, ICAR-National Research Institute for Integrated Pest Management (NRIIPM), New Delhi– Member
5. Dr G. K. Mahapatro, Principal Scientist, Entomology Division, ICAR- Indian Agricultural Research Institute, New Delhi– Member
Tenures of membership
Members are nominated by the Director General (ICMR) for a period of three years and their terms may be further renewed.
Secretariat
The EVCP Secretariat is based at ICMR Hq, New Delhi (see contact details below).
The products accepted for evaluation will be according to the Common Protocol.
• The products currently include, but are not limited to, the following:
• Insecticides for Indoor Residual Spraying (IRS)
• Long-Lasting Insecticidal Nets (LLINs)/Insecticide-Treated Nets (ITNs)
• Larvicides (Chemical, and biological/microbial, Insect Growth Regulators)
• Monomolecular films
• Insecticides for space spraying (fogging)
The EVCP Secretariat is based at ICMR Hq, New Delhi (see contact details below).
• Phase I: Laboratory evaluation
• Phase II: Small-scale field evaluation (e.g., in experimental huts, households or mosquito breeding habitats)
• Phase III: Large-scale field evaluation (village-scale, or area-wide field evaluation of larval control products)
• Applicant details
• Details such as specifications, formulation, ingredients, material safety, etc.to be given.
• Product Claim (in terms of vector species and evaluation phase I, II or III)
• Registration status
• Packaging & labeling
• Authorized contacts for the company
• Material safety data sheet (MSDS)
• Technical specifications/certificate of analysis (CoA) of formulated product
• Certificate of analysis of active ingredient in the product, if applicable
• Efficacy evaluation report
• Authorized Representative: Authorized to act for the manufacturer.
• Accurate Information: All submitted information is accurate.
• Update Commitment: Any changes will be reported to ICMR.
• Supporting Data: Product claims are backed by evidence.
• Independent Testing: ICMR independently conducts and reports the evaluation outcome.
• Testing Costs: Manufacturer bears all evaluation costs, besides supplying required quantity of test and reference items.
• Indian Council of Medical Research (ICMR) and its institutes
• National Centre for Vector Borne Diseases Control (NCVBDC)
• National Centre for Disease Control (NCDC)
• Central Insecticides Board & Registration Committee (CIB&RC)
- V.K.A. Polymers Pvt. Ltd.Veeralin LN (Phase III)
- ICMR-NIVCR, Puducherry
- ICMR-NITHR, Jabalpur
- ICMR-NIMR FU
September 2025 - V.K.A. Polymers Pvt. Ltd.MAGNet LN (Phase III)
- ICMR-NIVCR, Puducherry
- ICMR-NITHR, Jabalpur
- ICMR-NIMR FU, Nadiad
September 2025 - Kolar Consumer Products Private LimitedAlpha-cypermethrin (0.667%w/w) incorporated LLIN (Phase-I)
- ICMR-NIMR, Delhi
- HIL (India) Limited, New DelhiHILNET (Phase III)
- ICMR-NIVCR, Puducherry
- ICMR-NITHR, Jabalpur
- ICMR-NIMR FU, Nadiad
- HIL (India) Limited, New DelhiHILNEEM DT (Phase-I)
- ICMR-NIMR Delhi
- HIL (India) Limited, New DelhiHILNEEM SC
- ICMR-NIMR Delhi
- HIL (India) Limited, New DelhiHILNEEM SO
- ICMR-NIMR Delhi
Prospective applicants may contact the EVCP Secretariat at the following address
Dr. Lokesh Kori
Program Officer,
Indian Council of Medical Research
Email: icmr.evcp[at]icmr[dot]gov[dot]in






